Hypothalamic-pituitary-adrenal axis in abdominal obesity: Effects of dexfenfluramine

Clinical Endocrinology

Volumn 46, Issue 4, 1997, Pages 461-466

  Boushaki, F Z ^b   Rasio, E ^b   Serri, O ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXFENFLURAMINE; HYDROCORTISONE; NALOXONE; PLACEBO;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; OBESITY; ORAL DRUG ADMINISTRATION; PHARMACOLOGICAL BLOCKING; PHARMACOLOGICAL STIMULATION; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031005351     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.1620975.x     Document Type: Article

References (28)

1. Ashley, V.V., Fleury, M.O., Golay, A., Maeder, E. & Leathwood, P.D. (1985) Evidence for diminished bran 5-hydroxytryptamine biosynthesis in obese diabetic and non-diabetic humans. American Journal of Clinical Nutrition, 42, 1240-1245.
2. Bjórntorp, P. (1988) The association between obesity, adipose tissue distribution and disease. Acta Medico Scandinavian, 723 (Suppl.), 121-134.
3. Bjórntorp, P. (1995) Neuroendocrine abnormalities in human obesity. Metabolism, 44 (Suppl. 2), 38-41.
4. Blundell, J.E. & Nathan, C.J. (1978) Pharmacological manipulation of feeding behaviour: Possible influences of serotonin and dopamine on food intake. In Central Mechanism of Anorectic Drugs (eds. S. Garattini & R. Samanin), pp. 83-109, Raven, New York.
5. Burton, M.J., Cooper, S.J. & Popplewell, D.A. (1981) The effect of fenfluramine on the microsCructure of feeding and drinking in the ob/ob rat. British Journal of Pharmacology, 72, 621-633.
6. Delitala, G., Trainer, P.J., Oliva, O., Fanciulli, G. & Grossman, A.B. (1994) Opioid peptide and a-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man. Journal of Endocrinology, 141, 163-168.
7. Drent, M.L., Adèr, H.J. & Van der Veen, E.A. (1995) The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people. Journal Endocrinology Investigation, 18, 780-788.
8. Evans, D.J., Hoffmann, R.G., Kalkhoff, R.K. & Kissebah, A.H. (1983) Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women. Journal of Clinical Endocrinology and Metabolism, 57, 304-310.
9. Grossman, A. & Besser, G.M. (1982) Opiates control ACTH through a noradrenergic mechanism. Clinical Endocrinology, 17, 287-290.
10. Homes, M.C., Di Renzo, G., Beckford, U., Gillham, B. & Jones, M.T. (1982) Role of serotonin in the control of secretion of corticotrophin releasing factor. Journal of Endocrinology, 93, 151-160.
11. Jackson, R.V., Grice, J.E., Jackson, A.J. & Hockings, G.I. (1990) Naloxone-induced ACTH release in man is inhibited by clonidine. Clinical and Experimental Pharmacology and Physiology, 17, 179-184.
12. Kirschner, M.A., Samojlik, E., Drejka, M., Szmal, E., Schneider, G. & Ertel, N. (1990) Androgen-estrogen metabolism in women with upper body versus lower body obesity. Journal of Clinical Endocrinology and Metabolism, 70, 473-479.
13. Kissebah, A.H., Vydelingum, N., Murray, R., Evans, D.J., Hartz, A.J., Kalkhoff, R.K. & Adams, P.W. (1982) Relation of body fat distribution to metabolic complications of obesity. Journal of Clinical Endocrinology and Metabolism, 54, 254-260.
14. Kissebah, A.H. & Peiris, A.N. (1989) Biology of regional fat distribution: Relationship to non-insulin-dependent diabetes mellitus. Diabetes/Metabolism Revues, 5, 83-109.
15. Lewis, D.A. & Sherman, B.M. (1983) Serotonin stimulation of adrenocorticotropin secretion in man. Journal of Clinical Endocrinology and Metabolism, 58, 458-462.
16. Marin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S. & Bjorntorp, P. (1992) Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism, 41, 882-886.
17. Morley, J.E., Branetsky, N.G., Wingert, T.D., Carlson, H.E., Hershman, J.M., Melmed, S., Levin, S.R., Jamison, K.R., Weitman, R., Chang, R.J. & Varner, A.A. (1980) Endocrine effects of naloxone-induced opiate receptor blockade. Journal of Clinical Endocrinology and Metabolism, 50, 251-257.
18. Orth, D.N. (1992) Corticotropin-releasing hormone in humans. Endocrine Reviews, 13, 164-191.
19. Pasquali R., Cantobelli, S., Casimirri, F., Bortoluzzi, L., Boshchi, S., Capelli, M., Melchionda, N. & Barbara, L. (1992) The role of the opioid peptides in the development of hyperinsulinemia in obese women with abdominal body fat distribution. Metabolism, 41, 763-767.
20. Pasquali, R., Cantobelli, S., Casimirri, F., Capelli, M., Bortoluzzi, L., Flamia, R., Labate, A.M. & Barbara, L. (1993a) The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. Journal of Clinical Endocrinology and Metabolism, 77, 341-346.
21. Pasquali, R., Casimirri, F., Cantobelli, S., Buratti, P., Bortoluzzi, L., Capelli, M., Labate, A.M. & Barbara, L. (1993b) β-endorphin response to exongenous corticotrophin-releasing hormone in obese women with different patterns of body fat distribution. International Journal of Obesity and Related Metabolic Disorders, 17, 593-596.
22. Satta, M.A., Maussier, M.L., De Rosa, G., Valenza V., Testa, A., Saletnich, I., Napolitano, G. & Monaco, F. (1992) Effects of naloxone on adrenocorticotrophin (ACTH) and cortisol in obese subjects. Hormone and Metabolic Research, 24, 44-45.
23. Serri, O. & Adingra, N. (1994) La naloxone: évaluation de l'axe hypochalamon-hypophyso-surrénalien des patients porteurs d'adénomes hypophysaires. Revue Française d'Endocrinologie Clinique, 35, 517-523.
24. Torpy, D.J., Jackson, R.V., Grice, J.E., Hockings, G.I., Strakosch, C.R. & Topliss, D.J. (1993) Naloxone stimulation of ACTH secretion during petrosal sinus sampling in Cushing's syndrome. Clinical and Experimental Pharmacology and Physiology, 20, 299-302.
25. Trainer, P.J., Faria, M., Newell-Price, J., Browne, P., Kopelman, P., Couy, D.H., Besser, G.M. & Grossman, A.B. (1995) A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. Journal of Clinical Endocrinology and Metabolism, 80, 412-417.
26. Volavka, J., Cho, D., Mallya, A. & Bauman, J. (1979) Naloxone increases ACTH and cortisol levels in man. New England Journal of Medicine, 300, 1056-1057.
27. Wurtman, R.J. & Wurtman, J.J. (1986) Carbohydrate craving, obesity and brain serotonin. Appetite, 7, 99-103.
28. Zis, A.P., Haskett, R.F., Albala, A.A. & Carroll, B.J. (1984) Morphine inhibits cortisol and stimulates prolactin secretion in man. Psychoneuroendocrinology, 9, 423-127.